JPN clinical practice guidelines 2021 with easy-to-understand explanations for the management of acute pancreatitis

J Hepatobiliary Pancreat Sci. 2022 Oct;29(10):1057-1083. doi: 10.1002/jhbp.1146. Epub 2022 Apr 28.

Abstract

Background: In preparing the Japanese (JPN) guidelines for the management of acute pancreatitis 2021, the committee focused the issues raised by the results of nationwide epidemiological survey in 2016 in Japan.

Method: In addition to a systematic search using the previous JPN guidelines, papers published from January 2014 to September 2019 were searched for the contents to be covered by the guidelines based on the concept of GRADE system.

Results: Thirty-six clinical questions (CQ) were prepared in 15 subject areas. Based on the facts that patients diagnosed with severe disease by both Japanese prognostic factor score and contrast-enhanced computed tomography (CT) grade had a high fatality rate and that little prognosis improvement after 2 weeks of disease onset was not obtained, we emphasized the importance of Pancreatitis Bundles, which were shown to be effective in improving prognosis, and the CQ sections for local pancreatic complications had been expanded to ensure adoption of a step-up approach. Furthermore, on the facts that enteral nutrition for severe acute pancreatitis was not started early within 48 h of admission and that unnecessary prophylactic antibiotics was used in almost all cases, we emphasized early enteral nutrition in small amounts even if gastric feeding is used and no prophylactic antibiotics are administered in mild pancreatitis.

Conclusion: All the members of the committee have put a lot of effort into preparing the extensively revised guidelines in the hope that more people will have a common understanding and that better medical care will be spread.

Keywords: endoscopic intervention; local pancreatic complications; pancreatitis bundles; severity assessment; step-up approach.

Publication types

  • Practice Guideline

MeSH terms

  • Acute Disease
  • Anti-Bacterial Agents / therapeutic use
  • Enteral Nutrition
  • Humans
  • Pancreas
  • Pancreatitis* / therapy
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents